ArticleJournal of experimental & clinical cancer research : CR2018

Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer.

Yan Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.